Reuters logo
2 months ago
BRIEF-Bayer Healthcare terminates Acura's license, development agreement
July 5, 2017 / 8:46 PM / 2 months ago

BRIEF-Bayer Healthcare terminates Acura's license, development agreement

July 5 (Reuters) - Acura Pharmaceuticals Inc:

* Acura Pharmaceuticals - on June 28, co received written notice from Bayer Healthcare terminating Acura's license and development agreement with Bayer dated as of June 5, 2015

* Acura Pharmaceuticals - as a result of termination, Mainpointe Pharmaceutical has option to license co's impede technology with respect to product in U.S. and canada Source text: (bit.ly/2thYWNO) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below